The Important Roles of Natural Killer Cells in Liver Fibrosis

Area of Science:

• Immunology
• Hepatology
• Cell Biology

Background:

• Liver fibrosis, a hallmark of chronic liver disease, involves excessive extracellular matrix (ECM) accumulation driven by activated hepatic stellate cells (HSCs).
• Natural killer (NK) cells, crucial innate immune components, exhibit complex, dual roles in liver fibrosis progression, acting as both profibrotic and anti-fibrotic factors.
• Uncontrolled liver fibrosis can lead to cirrhosis and hepatocellular carcinoma (HCC).

Purpose of the Study:

• To review the cellular and molecular mechanisms governing NK cell interactions with HSCs in liver fibrosis.
• To summarize therapeutic strategies that modulate NK cell function to combat liver fibrosis.
• To highlight gaps in understanding the broader crosstalk involving NK cells in liver pathobiology.

Main Methods:

• Literature review of studies on NK cells, HSCs, and liver fibrosis.
• Analysis of cellular and molecular regulators of NK cell activity.
• Examination of therapeutic interventions targeting NK cells for fibrosis reversal.

Main Results:

• NK cells exert both pro- and anti-fibrotic effects, influencing HSC activation and survival.
• Regulatory T cells (Tregs) and EP3 molecules modulate NK cell cytotoxicity.
• Various treatments, including ADH3 inhibitors, microRNAs, NKG2D activators, and natural products, can enhance NK cell-mediated inhibition of liver fibrosis.

Conclusions:

• Targeting NK cell functions and their interplay with HSCs offers a potential therapeutic avenue for liver fibrosis.
• Further research is needed to elucidate the complex interactions between NK cells and other liver cells (hepatocytes, Kupffer cells, etc.) in fibrosis.
• Understanding these intricate cellular networks is essential for developing effective anti-fibrotic strategies.